Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -33.05 | N/A |
PEG Ratio (TTM) | -0.33 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 9.67 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -10.61% | N/A |
ROE (TTM) | -32.82% | N/A |
Net Profit Margin (TTM) | -31.15% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -13.93% | -21.57% | N/A |
Revenue | 5.71% | 22.33% | N/A |
Net Income | -17.43% | -28.60% | N/A |
Cash Flow | -23.98% | 33.51% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.37 | N/A |
Quick Ratio (TTM) | 2.37 | N/A |
D/E Ratio (TTM) | 1.01 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 2.73 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |